Activated B cells express functional Fas ligand
✍ Scribed by Michael Hahne; Toufic Renno; Michael Schroeter; Martin Irmler; Lars French; Thierry Bornand; H. Robson MacDonald; Jürg Tschopp
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 425 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Fas ligand (FasL, Apo‐1L) is a member of the tumor necrosis factor protein family and binding to its receptor (Fas, Apo‐1, CD95) triggers cell death through apoptosis. Ligand expression is restricted to cells with known cytolytic activity and found on hematopoietic cells of the T cell and natural killer lineage. Here we provide evidence that B lymphocytes can express FasL. Flow cytometric analysis revealed that FasL is expressed on the surface of B cells upon stimulation with either lipopolysaccharide or phorbol 12‐myristute 13‐acetate/ionomycin. FasL expression on activated B cells was confirmed by Western blot and reverse transcriptase polymerase chain reaction analysis. FasL on B cells is functional since lipopolysaccharide‐activated B lymphocytes derived from wild type, but not from g/d mutant mice, were able to kill Fas‐sensitive target cells. Our data suggest that the Fas system may contribute to the control of B cell homeostasis.
📜 SIMILAR VOLUMES
Primary cutaneous B-cell lymphomas (CBCLs) represent a rare, but distinct group of B-cell neoplasms with a different clinical behaviour to B-cell lymphomas secondarily involving the skin. Fas-Fas ligand (Fasl) expression was investigated in a group of primary and secondary CBCLs to gain an insight i
Langerhans cells (LC) are professional antigen-presenting cells of dendritic cell (DC) lineage and are critical for the induction of primary immune responses in skin. Following antigenic stimulation, LC migrate to regional lymph nodes and induce antigen-specific activation of T cells. After primary